Inorganic Chemistry
ARTICLE
with ethyl acetate (3 ꢁ 100 mL), and the combined organic layers were
dried over Na2SO4, filtered, and evaporated. The crude compound was
subjected to silica gel column chromatography and eluted with petro-
leum ether/ethyl acetate (70:30), which afforded pure 1,9-diformyl-
meso-(3,4,5-trimethoxyphenyl) dipyrromethane (8) as a light-brown
151.1, 153.1, 153.6, 184.3. HRMS. Calcd for C20H17BF2N2O5 [(M ꢀ
F)þ]: m/z 395.1215. Found: m/z 395.1197. IR (KBr, νmax): 633.1,
765.0, 1074.2, 1175.1, 1232.2, 1269.7, 1335.8, 1379.5, 1464.9, 1539.2,
1570.3, 1675.4, 2922.7.
1
solid in 67% yield (0.8 g). Mp: 168ꢀ169 °C. H NMR (400 MHz,
’ ASSOCIATED CONTENT
CDCl3, δ in ppm): 3.76 (s, 9H; ꢀOCH3), 5.45 (s, 1H; ꢀCH),
6.07ꢀ6.09 (m, 2H; py), 6.63 (s, 2H; Ar), 6.85ꢀ6.87 (m, 2H; py),
9.12 (s, 2H; ꢀNH), 10.86 (br s, 2H; ꢀCHO). HRMS. Calcd for
C20H20N2O5 [(M þ 1)þ]: m/z 369.1450. Found: m/z 369.1436.
General Procedure for 3,5-Diformylboron Dipyrro-
methenes (9ꢀ12). 1,9-Diformyl dipyrromethanes 5ꢀ8 (1.7 mmol)
were dissolved in dichloromethane (200 mL) and oxidized with DDQ
(2.04 mmol) at room temperature. The reaction mixture was allowed to
stir at room temperature for 30 min. Triethylamine (68 mmol), followed
by BF3.Et2O (85 mmol), was added to the reaction mixture successively
without any time delay, and stirring was continued at room temperature
for an additional 30 min. The reaction mixture was evaporated, and the
crude product was purified using silica gel column chromatography with
petroleum ether/ethyl acetate (75:25), which afforded pure 3,5-difor-
mylboron dipyrromethenes 9ꢀ12 as blue-greenish solids.
S
Supporting Information. Spectral data of all compounds,
b
fluorescence data, tables of crystal and absorption data, and X-ray
crystallographic data for compound 11 inCIFformat. Thismaterial
’ AUTHOR INFORMATION
Corresponding Author
*E-mail: ravikanth@chem.iitb.ac.in.
’ ACKNOWLEDGMENT
M.R. acknowledges financial support by the DST and BRNS.
M.R.R. thanks the CSIR for their research fellowship. We thank
the DST-funded National Single Crystal X-ray Diffraction Facil-
ity for diffraction data. We thank the Department of Chemistry
and Sophisticated Analytical Instrument Facility (SAIF), Indian
Institute of Technology Bombay, for instrumentation. We also
thank Dr. Evans Coutinho, Bombay College of Pharmacy for
providing computational facility and valuable inputs.
3,5-Diformyl-8-tolyl-4-bora-3a,4a-diaza-s-indacene (9).
1
Yield: 80 mg, 14%. Mp: 242ꢀ243 °C (dec). H NMR (400 MHz,
CDCl3, δ in ppm): 2.52 (s, 3H; ꢀCH3), 7.12 (d, 3J(H,H) = 4.27 Hz, 2H;
py), 7.20 (d, 3J(H,H) = 4.27 Hz, 2H; py), 7.43 (d, 3J(H,H) = 7.94 Hz,
2H; Ar), 7.53 (d, 3J(H,H) = 7.94 Hz, 2H; Ar), 10.48 (br s, 2H; ꢀCHO).
1
11B NMR (100 MHz, CDCl3, δ in ppm): 1.26 (t, J(BꢀF), 1B). 19F
1
NMR (300 MHz, CDCl3, δ in ppm): ꢀ130.8 (q, J(FꢀB), 2F). 13C
NMR (100 MHz, CDCl3, δ in ppm): 21.8, 120.2, 129.9, 130.6, 131.4,
132.9, 137.9, 143.8, 151.0, 153.8, 184.4. HRMS. Calcd for C18H13-
BF2N2O2 [(M ꢀ F)þ]: m/z 319.1054. Found: m/z 319.1042. IR (KBr,
νmax): 760.0, 997.2, 1135.1, 1186.8, 1232.5, 1268.7, 1342.4, 1387.6,
1477.7, 1542.4, 1567.7, 1672.9, 2924.6.
’ REFERENCES
(1) (a) Principles of Fluorescence Spectroscopy, 2nd ed.; Lakowicz,
J. R., Ed.; Kluwer Academic/Plenum Publishers: New York, 1999; pp
531ꢀ572. (b) Fluorescent Chemosensors for Ion and Molecule Recognition;
Desvergne, J.-P., Czarnik, A. W., Eds.; Kluwer Academic Publishers:
Dordrecht, The Netherlands, 1997. (c) Haugland, R. P. The Handbook.
A Guide to Fluorescent Probes and Labeling Technologies, 10th ed.;
Molecular Probes, Inc.: Eugene, OR, 2005; pp 935ꢀ947. (d) Molecular
Fluorescence. Principles and Applications; Valeur, B., Ed.; Wiley-VCH:
Weinheim, Germany, 2002. (e) Haugland, R. P. Handbook of Fluorescent
Probes and Research Products. Molecular Probes, 9th ed.; Molecular
Probes, Inc.: Eugene, OR, 2002; pp 827 ꢀ848.
3,5-Diformyl-8-(4-bromophenyl)-4-bora-3a,4a-diaza-s-in-
dacene (10). Yield: 40 mg, 9%. Mp: 238ꢀ239 °C (dec). H NMR
1
(400 MHz, CDCl3, δ in ppm): 7.06 (d, 3J(H,H) = 4.75 Hz, 2H; py), 7.20
(d, 3J(H,H) = 4.36 Hz, 2H; py), 7.49 (d, 3J(H,H) = 6.74 Hz, 2H; Ar),
3
7.74 (d, J(H,H) = 6.74 Hz, 2H; Ar), 10.48 (br s, 2H; ꢀCHO). 11B
NMR (100 MHz, CDCl3, δ in ppm): 1.24 (t, 1J(BꢀF), 1B). 19F NMR
1
(300 MHz, CDCl3, δ in ppm): ꢀ130.8 (q, J(FꢀB), 2F). 13C NMR
(100 MHz, CDCl3, δ in ppm): 120.6, 127.7, 131.9, 132.3, 132.6, 132.7,
137.7, 151.6, 184.2. HRMS. Calcd for C17H10BF2N2O2Br [(M ꢀ F)þ]:
m/z 382.9988. Found: m/z 382.9991. IR (KBr, νmax): 602.3, 782.2,
1043.5, 1132.3, 1228.4, 1261.7, 1339.7, 1382.3, 1472.6, 1545.3, 1562.6,
1669.9, 2924.3.
(2) (a) Wagner, R. W.; Lindsey, J. S. Pure Appl. Chem. 1996,
68, 1373–1380. (b) Thoresen, L. H.; Kim, H.; Welch, M. B.; Burghart,
A.; Burgess, K. Synlett 1998, 1276–1278. (c) Kim, H.; Burghart, A.;
Welch, M. B.; Reibenspies, J.; Burgess, K. Chem. Commun.
1999, 1889–1890. (d) Burghart, A.; Kim, H.; Welch, M. B.; Thoresen,
L. H.; Reibenspies, J.; Burgess, K. J. Org. Chem. 1999, 64, 7813–7819.
(e) Chen, J.; Burghart, A.; Wan, C.-W.; Thai, L.; Ortiz, C.; Reibenspies,
J.; Burgess, K. Tetrahedron Lett. 2000, 41, 2303–2307. (f) Chen, J.;
Burghart, A.; Derecskei-Kovacs, A.; Burgess, K. J. Org. Chem. 2000,
65, 2900–2906. (g) Montalban, A. G.; Herrera, A. J.; Johannsen, J.; Beck,
J.; Godet, T.; Vrettou, M.; White, A. J. P.; Williams, D. J. Tetrahedron
Lett. 2002, 43, 1751–1753. (h) Ulrich, G.; Ziessel, R. J. Org. Chem. 2004,
69, 2070–2083.
3,5-Diformyl-8-(4-methoxyphenyl)-4-bora-3a,4a-diaza-s-
indacene (11). Yield: 150 mg, 26%. Mp: 236ꢀ237 °C (dec). 1H NMR
(400 MHz, CDCl3, δ in ppm): 3.96 (s, 3H; ꢀOCH3), 7.12ꢀ7.14 (m,
4H; py þ Ar), 7.21 (d, 3J(H,H) = 4.36 Hz, 2H; py), 7.61ꢀ7.63 (d, 3J(H,
H) = 7.13 Hz, 2H; Ar), 10.47 (br s, 2H; ꢀCHO). 11B NMR (100 MHz,
CDCl3, δ in ppm): 1.28 (t, 1J(BꢀF), 1B). 19F NMR (300 MHz, CDCl3,
δ in ppm): ꢀ130.7 (q, 1J(FꢀB), 2F). 13C NMR (100 MHz, CDCl3, δ in
ppm): 55.9, 114.9, 120.1, 126.0, 132.6, 133.7, 137.7, 150.6, 153.3, 163.9,
184.4. HRMS. Calcd for C18H13BF2N2O3 [(M ꢀ F)þ]: m/z 335.1003.
Found: m/z 335.0992. IR (KBr, νmax): 629.3, 752.0, 815.9, 1176.5,
1232.9, 1265.6, 1339.1, 1385.1, 1466.0, 1537.9, 1571.1, 1671.0, 2923.5.
3,5-Diformyl-8-(3,4,5-trimethoxyphenyl)-4-bora-3a,4a-
diaza-s-indacene (12). Yield: 40 mg, 7%. Mp: 250ꢀ251 °C (dec).
1H NMR (400 MHz, CDCl3, δ in ppm): 3.93 (s, 6H; m-OCH3), 4.00 (s,
3H, p-OCH3), 6.84 (s, 2H; Ar), 7.18 (d, 3J(H,H) = 4.58, 2H; py), 7.21
(d, 3J(H,H) = 4.28, 2H; py), 10.48 (br s, 2H; ꢀCHO). 11B NMR (100
MHz, CDCl3, δ in ppm): 1.24 (t, 1J(BꢀF), 1B). 19F NMR (300 MHz,
(3) BODIPY is a registered trademark of Molecular Probes, Inc.,
Eugene, OR.
(4) (a) Rurack, K.; Kollmannsberger, M.; Resch-Genger, U.; Daub, J.
J. Am. Chem. Soc. 2000, 122, 968–969. (b) Rurack, K.; Kollmannsberger,
M.; Daub, J. Angew. Chem., Int. Ed. 2001, 40, 385–387. (c) Turfan, B.;
Akkaya, E. U. Org. Lett. 2002, 4, 2857–2859. (d) Gee, K. R.; Rukavish-
nikov, A.; Rothe, A. Comb. Chem. High Throughput Screening 2003,
6, 363–366. (e) Cha, N. R.; Moon, S. Y.; Chang, S.-K. Tetrahedron Lett.
2003, 44, 8265–8268. (f) Moon, S. Y.; Cha, N. R.; Kim, Y. H.; Chang,
S.-K. J. Org. Chem. 2004, 69, 181–183. (g) Gabe, Y.; Urano, Y.; Kikuchi,
K.; Kojima, H.; Nagano, T. J. Am. Chem. Soc. 2004, 126, 3357–3367.
(h) Coskun, A.; Akkaya, E. U. Tetrahedron Lett. 2004, 45, 4947–4949.
1
CDCl3, δ in ppm): ꢀ130.5 (q, J(FꢀB), 2F). 13C NMR (100 MHz,
CDCl3, δ in ppm): 56.7, 61.4, 109.1, 120.3, 128.5, 132.8, 137.8, 142.2,
4399
dx.doi.org/10.1021/ic102499h |Inorg. Chem. 2011, 50, 4392–4400